TLRY
Companies
NASDAQ
Tilray Brands Inc.
Health Care
$0.38
-$0.95 (-71.18%)
Price Chart
Overview
About TLRY
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
Market Cap
$1.5B
Volume
9.3M
Avg. Volume
12.4M
P/E Ratio
-6.5185714
Dividend Yield
0.00%
Employees
1.0K
Company Information
Exchange
NASDAQ
Sector
Health Care
Industry
Drug Manufacturers - Specialty & Generic
Website
Latest News for TLRY
Cannabis/Beer Company Tilray Outlines Plan To Reduce Its Beverage Portfolio, Reports Mixed Q2 Earnings
January 10, 2025
We think Trump may support cannabis legalization, says Tilray CEO Irwin Simon
January 2, 2025
We need to make beer in the US, Tilray CEO says
December 16, 2024
Why Tilray Brands, Inc. (TLRY) Dipped More Than Broader Market Today
June 17, 2025
Risk & Correlation Analysis
Market Correlation
1.43
High Correlation
Volatility
High (0.73)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, TLRY shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$1.5B
Volume9.3M
P/E Ratio-6.52
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
October 10, 2024Related Securities
Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025